Yıl: 2022 Cilt: 33 Sayı: 9 Sayfa Aralığı: 777 - 784 Metin Dili: İngilizce DOI: 10.5152/tjg.2022.21911 İndeks Tarihi: 26-10-2022

Mitochondrial Homeostasis and Mast Cells in Experimental Hepatic Ischemia-Reperfusion Injury of Rats

Öz:
Background: Ischemia-reperfusion injury is a histopathological event and is an important cause of morbidity and mortality after hepatobiliary surgery. We aimed to investigate the protective effect of uridine on hepatic ischemia-reperfusion injury in rats. Methods: The animals were divided into 4 groups (n = 8): group I (control), group II: ischemia-reperfusion (30 minutes ischemia and 120 minutes reperfusion), group III: ischemia-reperfusion + uridine (at the beginning of reperfusion), and group IV: ischemia-reperfusion + uridine (5 minutes before ischemia-reperfusion). Uridine was administered a single dose of 30 mg/kg IV. The 3 elements of the hepatoduodenal ligament (hepatic artery, portal vein, and biliary tract) were obliterated for 30 minutes. Then hepatic reperfusion was achieved for 120 minutes. Results: In the ischemia-reperfusion group, both liver tissues and serum chymase activity and high-temperature requirement A2 levels were higher. Severe central vein dilatation and congestion, widening sinusoidal range, diffuse necrotic hepatocytes and dense erythrocyte accumulation in sinusoids, and strongly inducible nitric oxide synthase expression were seen in the ischemia-reperfusion group. A clear improvement was seen in both uridine co-administration and pretreatment groups. Conclusion: Our results revealed that uridine limits the development of liver damage under conditions of ischemia-reperfusion, thus contributing to an increase in hepatocyte viability.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Aldi S, Marino A, Tomita K, et al. E-NTPDase1/CD39 modulates renin release from heart mast cells during ischemia/reperfusion: a novel cardioprotective role. FASEB J. 2015;29(1):61-69. [CrossRef]
  • 2. Atiakshin D, Buchwalow I, Tiemann M. Mast cell chymase: morphofunctional characteristics. Histochem Cell Biol. 2019;152(4):253- 269. [CrossRef]
  • 3. Barrier A, Olaya N, Chiappini F, et al. Ischemic preconditioning modulates the expression of several genes, leading to the overproduction of IL-1RA, iNOS, and Bcl-2 in a human model of liver ischemia-reperfusion. FASEB J. 2005;19(12):1617-1626. [CrossRef]
  • 4. Bertoni S, Ballabeni V, Barocelli E, Tognolini M. Mesenteric ischemia-reperfusion: an overview of preclinical drug strategies. Drug Discov Today. 2018;23(7):1416-1425. [CrossRef]
  • 5. Bulion VV, Selina EN, Krylova IB. Zashchitnoe deĭstvie uridina na metabolicheskie protsessy v miokarde krys pri ego reperfuzionnom povrezhdenii [Protective effect of uridine on metabolic processes in rat myocardum during its ischemia/reperfusion damage]. Biomed Khim. 2019;65(5):398-402. [CrossRef]
  • 6. Cansev M. Uridine and cytidine in the brain: their transport and utilization. Brain Res Rev. 2006;52(2):389-397. [CrossRef]
  • 7. Caraceni P, Domenicali M, Vendemiale G, et al. The reduced tolerance of rat fatty liver to ischemia reperfusion is associated with mitochondrial oxidative injury. J Surg Res. 2005;124(2):160-168. [CrossRef]
  • 8. Carini R, Alchera E, De Cesaris MG, et al. Purinergic P2Y2 receptors promote hepatocyte resistance to hypoxia. J Hepatol. 2006;45(2):236- 245. [CrossRef]
  • 9. Cinelli MA, Do HT, Miley GP, Silverman RB. Inducible nitric oxide synthase: regulation, structure, and inhibition. Med Res Rev. 2020;40(1):158-189. [CrossRef]
  • 10. Dar WA, Sullivan E, Bynon JS, Eltzschig H, Ju C. Ischaemia reperfusion injury in liver transplantation: cellular and molecular mechanisms. Liver Int. 2019;39(5):788-801. [CrossRef]
  • 11. Elshazly S, Soliman E. PPAR gamma agonist, pioglitazone, rescues liver damage induced by renal ischemia/reperfusion injury. Toxicol Appl Pharmacol. 2019;362:86-94. [CrossRef]
  • 12. Froogh G, Pinto JT, Le Y, et al. Chymase-dependent production of angiotensin II: an old enzyme in old hearts. Am J Physiol Heart Circ Physiol. 2017;312(2):H223-H231. [CrossRef]
  • 13. Govindasamy M, Wang SF, Subramanian B, Ramalingam RJ, Al- Lohedan H, Sathiyan A. A novel electrochemical sensor for determination of DNA damage biomarker (8-hydroxy-2′-deoxyguanosine) in urine using sonochemically derived graphene oxide sheets covered zinc oxide flower modified electrode. Ultrason Sonochem. 2019;58: 104622. [CrossRef]
  • 14. He Z, Ma C, Yu T, et al. Activation mechanisms and multifaceted effects of mast cells in ischemia reperfusion injury. Exp Cell Res. 2019;376(2):227-235. [CrossRef]
  • 15. Jarido V, Kennedy L, Hargrove L, et al. The emerging role of mast cells in liver disease. Am J Physiol Gastrointest Liver Physiol. 2017; 313(2):G89-G101. [CrossRef]
  • 16. Krick S, Shi S, Ju W, et al. Mpv17l protects against mitochondrial oxidative stress and apoptosis by activation of Omi/HtrA2 protease. Proc Natl Acad Sci U S A. 2008;105(37):14106-14111. [CrossRef]
  • 17. Lin J, Huang HF, Yang SK, et al. The effect of ginsenoside Rg1 in hepatic ischemia reperfusion (I/R) injury ameliorates ischemiareperfusion- induced liver injury by inhibiting apoptosis. Biomed Pharmacother. 2020;129:110398. [CrossRef]
  • 18. Maurer CA, Walensi M, Käser SA, Künzli BM, Lötscher R, Zuse A. Liver resections can be performed safely without Pringle maneuver: a prospective study. World J Hepatol. 2016;8(24):1038-1046. [CrossRef]
  • 19. Nehme A, Zouein FA, Zayeri ZD, Zibara K. An update on the tissue renin angiotensin system and its role in physiology and pathology. J Cardiovasc Dev Dis. 2019;6(2):14. [CrossRef]
  • 20. Pejler G. Novel insight into the in vivo function of mast cell chymase: lessons from knockouts and inhibitors. J Innate Immun. 2020;12(5):357-372. [CrossRef]
  • 21. Sasaki M, Joh T. Oxidative stress and ischemia-reperfusion injury in gastrointestinal tract and antioxidant, protective agents. J Clin Biochem Nutr. 2007;40(1):1-12. [CrossRef]
  • 22. Setzer B, Lebrecht D, Walker UA. Pyrimidine nucleoside depletion sensitizes to the mitochondrial hepatotoxicity of the reverse transcriptase inhibitor stavudine. Am J Pathol. 2008;172(3):681-690. [CrossRef]
  • 23. Sherif IO, Al-Shaalan NH. Vildagliptin attenuates hepatic ischemia/reperfusion injury via the TLR4/NF-κB signaling pathway. Oxid Med Cell Longev. 2018;2018:3509091. [CrossRef]
  • 24. Wertheim JA, Petrowsky H, Saab S, Kupiec-Weglinski JW, Busuttil RW. Major challenges limiting liver transplantation in the United States. Am J Transplant. 2011;11(9):1773-1784. [CrossRef]
  • 25. Wu MY, Yiang GT, Liao WT, et al. Current mechanistic concepts in ischemia and reperfusion injury. Cell Physiol Biochem. 2018;46(4):1650-1667. [CrossRef]
  • 26. Xu Z, Lin J, Xie Y, Tang H, Xie J, Zeng R. HtrA2 is required for inflammatory responses in BMDMs via controlling TRAF2 stability in collagen-induced arthritis. Mol Immunol. 2021;129:78-85. [CrossRef]
  • 27. Xue Y, Li M, Xue Y, et al. Mechanisms underlying the protective effect of tannic acid against arsenic trioxideinduced cardiotoxicity in rats: potential involvement of mitochondrial apoptosis. Mol Med Rep. 2020;22(6):4663-4674. [CrossRef]
  • 28. Zhou H, Yuan D, Gao W, et al. Loss of high-temperature requirement protein A2 protease activity induces mitonuclear imbalance via differential regulation of mitochondrial biogenesis in sarcopenia. IUBMB Life. 2020;72(8):1659-1679. [CrossRef]
  • 29. Moreno D, Sobarzo CM, Lustig L, Rodríguez Peña MG, Guazzone VA. Effect of ketotifen fumarate on experimental autoimmune orchitis and torsion of the spermatic cord. Asian J Androl. 2020;22(1):112-117. [CrossRef]
  • 30. Huang PJ, Gan XL, Liu JP, Liu DZ, Wang YL, Hei ZQ. Effects of anti-histamine treatment on liver injury triggered by small intestinal ischemia reperfusion in rats. Chin J Physiol. 2014;57(5):271-278. [CrossRef]
APA KOC S, DOĞAN H, KARATAŞ Ö, erdogan m, Polat V (2022). Mitochondrial Homeostasis and Mast Cells in Experimental Hepatic Ischemia-Reperfusion Injury of Rats. , 777 - 784. 10.5152/tjg.2022.21911
Chicago KOC SULEYMAN,DOĞAN Halef Okan,KARATAŞ Özhan,erdogan mehmet mustafa,Polat Vural Mitochondrial Homeostasis and Mast Cells in Experimental Hepatic Ischemia-Reperfusion Injury of Rats. (2022): 777 - 784. 10.5152/tjg.2022.21911
MLA KOC SULEYMAN,DOĞAN Halef Okan,KARATAŞ Özhan,erdogan mehmet mustafa,Polat Vural Mitochondrial Homeostasis and Mast Cells in Experimental Hepatic Ischemia-Reperfusion Injury of Rats. , 2022, ss.777 - 784. 10.5152/tjg.2022.21911
AMA KOC S,DOĞAN H,KARATAŞ Ö,erdogan m,Polat V Mitochondrial Homeostasis and Mast Cells in Experimental Hepatic Ischemia-Reperfusion Injury of Rats. . 2022; 777 - 784. 10.5152/tjg.2022.21911
Vancouver KOC S,DOĞAN H,KARATAŞ Ö,erdogan m,Polat V Mitochondrial Homeostasis and Mast Cells in Experimental Hepatic Ischemia-Reperfusion Injury of Rats. . 2022; 777 - 784. 10.5152/tjg.2022.21911
IEEE KOC S,DOĞAN H,KARATAŞ Ö,erdogan m,Polat V "Mitochondrial Homeostasis and Mast Cells in Experimental Hepatic Ischemia-Reperfusion Injury of Rats." , ss.777 - 784, 2022. 10.5152/tjg.2022.21911
ISNAD KOC, SULEYMAN vd. "Mitochondrial Homeostasis and Mast Cells in Experimental Hepatic Ischemia-Reperfusion Injury of Rats". (2022), 777-784. https://doi.org/10.5152/tjg.2022.21911
APA KOC S, DOĞAN H, KARATAŞ Ö, erdogan m, Polat V (2022). Mitochondrial Homeostasis and Mast Cells in Experimental Hepatic Ischemia-Reperfusion Injury of Rats. Turkish Journal of Gastroenterology, 33(9), 777 - 784. 10.5152/tjg.2022.21911
Chicago KOC SULEYMAN,DOĞAN Halef Okan,KARATAŞ Özhan,erdogan mehmet mustafa,Polat Vural Mitochondrial Homeostasis and Mast Cells in Experimental Hepatic Ischemia-Reperfusion Injury of Rats. Turkish Journal of Gastroenterology 33, no.9 (2022): 777 - 784. 10.5152/tjg.2022.21911
MLA KOC SULEYMAN,DOĞAN Halef Okan,KARATAŞ Özhan,erdogan mehmet mustafa,Polat Vural Mitochondrial Homeostasis and Mast Cells in Experimental Hepatic Ischemia-Reperfusion Injury of Rats. Turkish Journal of Gastroenterology, vol.33, no.9, 2022, ss.777 - 784. 10.5152/tjg.2022.21911
AMA KOC S,DOĞAN H,KARATAŞ Ö,erdogan m,Polat V Mitochondrial Homeostasis and Mast Cells in Experimental Hepatic Ischemia-Reperfusion Injury of Rats. Turkish Journal of Gastroenterology. 2022; 33(9): 777 - 784. 10.5152/tjg.2022.21911
Vancouver KOC S,DOĞAN H,KARATAŞ Ö,erdogan m,Polat V Mitochondrial Homeostasis and Mast Cells in Experimental Hepatic Ischemia-Reperfusion Injury of Rats. Turkish Journal of Gastroenterology. 2022; 33(9): 777 - 784. 10.5152/tjg.2022.21911
IEEE KOC S,DOĞAN H,KARATAŞ Ö,erdogan m,Polat V "Mitochondrial Homeostasis and Mast Cells in Experimental Hepatic Ischemia-Reperfusion Injury of Rats." Turkish Journal of Gastroenterology, 33, ss.777 - 784, 2022. 10.5152/tjg.2022.21911
ISNAD KOC, SULEYMAN vd. "Mitochondrial Homeostasis and Mast Cells in Experimental Hepatic Ischemia-Reperfusion Injury of Rats". Turkish Journal of Gastroenterology 33/9 (2022), 777-784. https://doi.org/10.5152/tjg.2022.21911